The decision to take B12 and iron together should be made in consultation with a healthcare provider
How to Dose KLOW (The Research Protocol) The documented research protocol for the 80 mg KLOW vial uses a single fixed per-dose amount, then varies frequency across a cycle rather than changing the dose size
TB-500 and Thymosin Beta-4 are also prohibited by WADA/USADA under S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics), applicable at all times both in-competition and out-of-competition TB-500 / Thymosin Beta-4 Clinical Trials: The RGN-352 and RGN-259 Programs RegeneRx Biopharmaceuticals has pursued two clinical development programs for Thymosin Beta-4, providing the most substantial human clinical data available for any TB-500-related compound: RGN-352 (Injectable Thymosin Beta-4 for Cardiac Repair): Phase 1 trial (completed): A double-blind, placebo-controlled study enrolled 40 healthy volunteers across four cohorts of 10 subjects each, testing escalating dose levels of intravenous Thymosin Beta-4 administered daily over 14 days
A standard 250 mcg dose draws to 15 units on an insulin syringe
The standard NHS schedule For a confirmed deficiency, the NHS treatment pathway sets out: Loading phase: 1mg of hydroxocobalamin on alternate days for up to two weeks (longer if there are neurological symptoms), to refill your stores
